-
121
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
Published 2025-01-01Subjects: “…immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
122
Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis
Published 2025-01-01Subjects: Get full text
Article -
123
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Published 2025-02-01Subjects: Get full text
Article -
124
-
125
-
126
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
127
Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
Published 2025-02-01Subjects: Get full text
Article -
128
-
129
Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
130
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
Published 2025-01-01Subjects: Get full text
Article -
131
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
132
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
133
Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
Published 2025-12-01Subjects: Get full text
Article -
134
The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumors
Published 2025-01-01Subjects: Get full text
Article -
135
Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
Published 2025-03-01Subjects: Get full text
Article -
136
-
137
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
138
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Published 2025-02-01Subjects: Get full text
Article -
139
Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
Published 2023-04-01Subjects: “…immune checkpoint blockade…”
Get full text
Article -
140